OBALON THERAPEUTICS INC - COM (OBLN)

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
7,563,219
Share change
+428,477
Total reported value
$74,951,392
Price per share
$9.91
Number of holders
57
Value change
+$4,243,800
Number of buys
30
Number of sells
17

Institutional Holders of OBALON THERAPEUTICS INC - COM (OBLN) as of Q2 2017

As of 30 Jun 2017, OBALON THERAPEUTICS INC - COM (OBLN) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,563,219 shares. The largest 10 holders included InterWest Venture Management Co, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Tamarack Advisers, LP, KORNITZER CAPITAL MANAGEMENT INC /KS, BlackRock Inc., LEVEL FOUR ADVISORY SERVICES, LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, C WorldWide Group Holding A/S, MILLENNIUM MANAGEMENT LLC, and WADDELL & REED FINANCIAL INC. This page lists 57 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.